Jiangsu Hengrui Pharmaceuticals Co Ltd

Common Name
Jiangsu Hengrui Pharmaceuticals
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
20,238
Ticker
600276
Exchange
SHANGHAI STOCK EXCHANGE
Description
Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a prominent player in the biopharmaceutical industry, focused on the research, development, manufacturing, and marketing of a comprehensive range of medica...

Jiangsu Hengrui Pharmaceuticals Waste Data Preview

In 2023, Jiangsu Hengrui Pharmaceuticals conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Jiangsu Hengrui Pharmaceuticals’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Jiangsu Hengrui Pharmaceuticals generated a total of 18,931 metric tonnes of waste.

Of this amount, 97.69% of Jiangsu Hengrui Pharmaceuticals's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 2.31% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Jiangsu Hengrui Pharmaceuticals’s Hazardous vs Non-Hazardous Waste Over Time

20212022202305 k10 k15 k20 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Jiangsu Hengrui Pharmaceuticals reduced the environmental impact of its waste?

Since 2021, Jiangsu Hengrui Pharmaceuticals's total waste generation increased by 29.42%, including a 30.96% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.

Over the same period, Jiangsu Hengrui Pharmaceuticals's hazardous waste share remained stable both over the long term and in 2023, reflecting consistent but static performance in managing hazardous materials.

Overall, Jiangsu Hengrui Pharmaceuticals is producing more waste without a change in hazardousness, implying that operational growth is not being accompanied by stronger safeguards against environmental and human health risks.

Want Full Access to Jiangsu Hengrui Pharmaceuticals's Waste Management Dataset?
Sign Up